Yakumed Limited

Yakumed is the world leading experts in the Japanese healthcare market. We partner with our customers in their market expansion to Japan. We support all regulatory activities such as PMDA consultation, Orphan Drug Designation, product launch and post-marketing variations. 

Japan is the world third largest pharmaceutical market with over USD $100 billion. Integrating Japan into your global clinical and commercial strategy will boost your sales considerably.

Yakumed has partnered with over 70 biotech and pharma companies to develop and launch their pharmaceutical drugs in Japan. 

Yakumed is highly regarded for its unmatched expertise in the Japanese healthcare.